Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Retail — Organized & E-Commerce.”
₹6,136 Cr revenue.
COGS 75.6%, employees 11.8%.
“pharmacy operations grew by 15.”
“My first question, is that, Madhav, could you explain that 10% plus, you know, SSG? We've seen that after some time now, and you also spoke about in your opening comments, Sujit mentioned the 18.”
“consolidated revenue for the quarter stood at 18,061 million.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 11.2%▲ | 8.9% |
| ROCE | 12.8%▲ | 11.0% |
| Net Margin | 3.1% | 3.1% |
| EBITDA Margin | 9.7%▲ | 7.6% |
| Debt To Equity | 0.00x▼ | 0.11x |
| Rev Growth 3yr | 17.5%▼ | 22.2% |
| EPS Growth 3yr | 16.1%▼ | 21.8% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | ₹6,538 Cr +6.5% | ₹6,136 Cr +9.1% | ₹5,625 Cr +23.4% | ₹4,558 Cr +20.6% | ₹3,779 Cr |
| Other Income | ₹67 Cr +36.8% | ₹49 Cr +21.5% | ₹40 Cr -13.2% | ₹46 Cr +46.9% | ₹31 Cr |
| Total Income | ₹6,604 Cr +6.8% | ₹6,185 Cr +9.2% | ₹5,665 Cr +23.1% | ₹4,604 Cr +20.8% | ₹3,811 Cr |
| COGS | ₹4,822 Cr +3.9% | ₹4,641 Cr +5.7% | ₹4,392 Cr +23.4% | ₹3,558 Cr +19.3% | ₹2,982 Cr |
| ₹6,348 Cr +5.8% | ₹6,001 Cr +7.3% | ₹5,591 Cr +22.7% | ₹4,556 Cr +23.4% | ₹3,693 Cr | |
| Profit Before Tax | ₹256 Cr +39.7% | ₹183 Cr +149.6% | ₹73 Cr +55.7% | ₹47 Cr -60.0% | ₹118 Cr |
| ₹49 Cr +48.7% | ₹33 Cr +320.2% | ₹8 Cr ↑ Recovery | (₹3 Cr) ↓ Decline | ₹23 Cr | |
| Net Profit | ₹207 Cr +37.8% | ₹150 Cr +129.1% | ₹66 Cr +30.9% | ₹50 Cr -47.1% | ₹95 Cr |
| Profit (Owners) | ₹207 Cr +37.7% | ₹150 Cr +129.6% | ₹65 Cr +31.6% | ₹50 Cr -48.1% | ₹96 Cr |
| Minority Interest | (₹0.02 Cr) +79.8% | (₹0.09 Cr) ↓ Decline | ₹0.10 Cr -69.6% | ₹0.34 Cr ↑ Recovery | (₹1 Cr) |
| Other Comprehensive Income | ₹0.15 Cr 0.0% | ₹0.15 Cr ↑ Recovery | (₹0.06 Cr) ↓ Decline | ₹0.33 Cr -81.7% | ₹2 Cr |
| EPS | ₹17.28 | ₹12.56 | ₹5.48 | ₹4.17 | ₹8.03 |
| Diluted Shares | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers...
Gangadi Madhukar Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulat...
Submission of Newspaper clippings
Lone Furrow Investment Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and T...
, Agilemed Investment Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Ta...
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
No dividend history available for this company.